IDiyas

For the Inventor, By the Inventor

Anatoly Dritschilo

Bethesda, MD, United States of America

Anatoly Dritschilo

Webpage
USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 4.2

ph-index = 8

Forward Citations = 236(Granted Patents)


Location History:

  • Washington, DC (US) (2003)
  • Rockville, MD (US) (2017 - 2023)
  • Bethesda, MD (US) (1996 - 2024)

Company Filing History:

goldMedal15 out of 484 
 
Georgetown University
 patents
silverMedal9 out of 9 
 
Shuttle Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 6 
 
Neopharm, Inc.
 patents
4. 1 out of 2,340 
 
University of Illinois
 patents
where one patent can have more than one assignee

Years Active: 1996-2025

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents
1. 12357650 - Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation (2025-07-15),
2. 12077515 - Selective histone deacetylase inhibitors for the treatment of human disease (2024-09-03),
3. 11654157 - Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation (2023-05-23),
4. 11584733 - Selective histone deacetylase inhibitors for the treatment of human disease (2023-02-21),
5. 11407723 - Selective histone deacetylase inhibitors for the treatment of human disease (2022-08-09),
6. 11034667 - Selective histone deacetylase inhibitors for the treatment of human disease (2021-06-15),
7. 10745352 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof (2020-08-18),
8. 10730834 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof (2020-08-04),
9. 9809539 - Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof (2017-11-07),
10. 8748463 - Histone deacetylase inhibitors and methods of use thereof (2014-06-10),
11. 8653278 - Isoform selective HDAC inhibitors (2014-02-18),
12. 8293513 - Histone deacetylase inhibitors (2012-10-23),
13. 8222451 - Histone deacetylase inhibitors and methods of use thereof (2012-07-17),
14. 7842835 - Histone deacetylase inhibitors and methods of use thereof (2010-11-30),
15. 7442520 - Gene BRCC-3 and diagnostic and therapeutic uses thereof (2008-10-28),

Title: The Innovative Journey of Anatoly Dritschilo

Introduction: Anatoly Dritschilo, a distinguished inventor based in Bethesda, MD (US), has made significant contributions to the field of innovation and patents.

Latest Patents: Anatoly Dritschilo holds several patents in the medical field, focusing on advancements in cancer treatment and radiation therapy.

Career Highlights: With a career spanning several decades, Dritschilo has been a pioneer in developing cutting-edge technologies for cancer research and treatment. His work has led to groundbreaking discoveries in the fight against cancer.

Collaborations: Throughout his career, Anatoly Dritschilo has collaborated with leading researchers, medical professionals, and institutions to further the impact of his inventions. His collaborative efforts have resulted in the development of innovative solutions with real-world applications.

Conclusion: Anatoly Dritschilo's dedication to innovation and his relentless pursuit of advancements in cancer treatment have solidified his reputation as a visionary inventor in the medical field. His work continues to inspire future generations of inventors and researchers in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…